Total Payments
$15,201
2024 Payments
$2,500
Companies
46
Transactions
819
Medicare Patients
3,370
Medicare Billing
$564,910
Payment Breakdown by Category
Food & Beverage$14,702 (96.7%)
Education$498.64 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,702 | 809 | 96.7% |
| Education | $498.64 | 10 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,774 | 240 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,521 | 122 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,679 | 88 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $847.32 | 34 | $0 (2024) |
| GENZYME CORPORATION | $768.57 | 29 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $606.76 | 14 | $0 (2024) |
| Genentech USA, Inc. | $592.30 | 34 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $473.75 | 43 | $0 (2021) |
| United Therapeutics Corporation | $471.78 | 12 | $0 (2024) |
| Grifols USA, LLC | $405.58 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,500 | 123 | GlaxoSmithKline, LLC. ($403.91) |
| 2023 | $2,520 | 106 | AstraZeneca Pharmaceuticals LP ($408.89) |
| 2022 | $2,341 | 113 | AstraZeneca Pharmaceuticals LP ($537.25) |
| 2021 | $1,974 | 112 | AstraZeneca Pharmaceuticals LP ($402.56) |
| 2020 | $1,243 | 80 | GlaxoSmithKline, LLC. ($308.86) |
| 2019 | $1,583 | 105 | GlaxoSmithKline, LLC. ($309.10) |
| 2018 | $1,719 | 104 | GlaxoSmithKline, LLC. ($397.96) |
| 2017 | $1,320 | 76 | Boehringer Ingelheim Pharmaceuticals, Inc. ($278.47) |
All Payment Transactions
819 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $2.43 | General |
| Category: HFCWO | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $57.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $4.93 | General |
| Category: HFCWO | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $111.41 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.80 | General |
| Category: HFCWO | ||||||
| 11/20/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $127.06 | General |
| Category: PULMONOLOGY | ||||||
| 11/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 777 | 1,599 | $196,224 | $115,665 |
| 2022 | 9 | 879 | 2,104 | $266,873 | $147,385 |
| 2021 | 9 | 984 | 2,480 | $302,793 | $174,572 |
| 2020 | 9 | 730 | 1,726 | $215,257 | $127,288 |
Total Patients
3,370
Total Services
7,909
Medicare Billing
$564,910
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 179 | 892 | $113,284 | $81,725 | 72.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 229 | $20,152 | $14,249 | 70.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 118 | 134 | $27,336 | $13,426 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $6,688 | $3,938 | 58.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 97 | 102 | $6,732 | $893.76 | 13.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 97 | 102 | $15,300 | $766.36 | 5.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 97 | 102 | $6,732 | $665.99 | 9.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 206 | 1,204 | $152,908 | $95,200 | 62.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 148 | 165 | $33,660 | $17,112 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 260 | $22,880 | $15,944 | 69.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 114 | $10,032 | $6,275 | 62.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 33 | $12,705 | $5,652 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $8,096 | $4,906 | 60.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 90 | 94 | $6,204 | $882.26 | 14.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 91 | 95 | $14,250 | $764.48 | 5.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 89 | 93 | $6,138 | $649.34 | 10.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 233 | 1,449 | $184,023 | $116,954 | 63.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 168 | 262 | $23,056 | $16,804 | 72.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 127 | 144 | $29,376 | $15,201 | 51.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 212 | $18,656 | $11,953 | 64.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 72 | 72 | $12,672 | $8,614 | 68.0% |
| 32555 | Removal of fluid from chest cavity with imaging guidance | Facility | 2021 | 15 | 15 | $3,750 | $1,329 | 35.4% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 95 | 95 | $6,270 | $912.00 | 14.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 94 | 95 | $14,250 | $773.62 | 5.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 21 | 21 | $3,150 | $700.80 | 22.2% |
About Dr. Matthew Cheng, MD
Dr. Matthew Cheng, MD is a Pulmonary Disease healthcare provider based in Salem, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801845524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Cheng, MD has received a total of $15,201 in payments from pharmaceutical and medical device companies, with $2,500 received in 2024. These payments were reported across 819 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($14,702).
As a Medicare-enrolled provider, Cheng has provided services to 3,370 Medicare beneficiaries, totaling 7,909 services with total Medicare billing of $564,910. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Salem, OH
- Active Since 05/09/2006
- Last Updated 06/19/2009
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1801845524
Products in Payments
- DUPIXENT (Biological) $1,682
- NUCALA (Biological) $1,233
- TRELEGY ELLIPTA (Drug) $816.85
- STIOLTO RESPIMAT (Drug) $641.10
- OFEV (Drug) $595.12
- FASENRA (Biological) $519.85
- TEZSPIRE (Biological) $506.97
- Xolair (Biological) $415.33
- ACTHAR (Biological) $393.99
- Prolastin-C Liquid (Biological) $356.91
- XYWAV (Drug) $315.00
- OPSUMIT (Drug) $298.46
- BREZTRI (Drug) $277.71
- SYMBICORT (Drug) $275.95
- AIRSUPRA (Drug) $255.81
- FASENRA (Drug) $240.33
- TYVASO (Drug) $236.60
- XARELTO (Drug) $226.13
- GLASSIA (Biological) $222.49
- BREO (Drug) $216.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Salem
James Witten, Md, MD
Pulmonary Disease — Payments: $167,998
Pulmonary Disease $167,998
David Killeen, D.o, D.O
Pulmonary Disease — Payments: $132,565
Pulmonary Disease $132,565
Nelson Greene, Md, MD
Pulmonary Disease — Payments: $33,883
Pulmonary Disease $33,883
Douglas Dorsey, M.d, M.D
Pulmonary Disease — Payments: $24,524
Pulmonary Disease $24,524
Steven Marvel, M.d, M.D
Pulmonary Disease — Payments: $11,509
Pulmonary Disease $11,509
Kamran Firoozi, M.d, M.D
Pulmonary Disease — Payments: $7,489
Pulmonary Disease $7,489